Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 7, 2018

Total Value: $211M (100.0% shares, 0.0% debt)

Holdings (14)

REPL Replimune 38.9%

Value $82.17M Shares 5,103,455 Est. Cost $17.53 Unrealized 0.0%

— Paratek Pharmaceuticals 11.9%

Value $25.22M Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Translate Bio 11.5%

Value $24.38M Shares 2,437,601 Est. Cost $12.65 Unrealized —

— ObsEva 8.5%

Value $18.02M Shares 999,364 Est. Cost $9.76 Unrealized —

— Kezar Life Sciences 7.0%

Value $14.84M Shares 693,272 Est. Cost $17.30 Unrealized —

SNNAQ Sienna Biopharmaceuticals 5.3%

Value $11.24M Shares 758,610 Est. Cost $21.95 Unrealized -27.6%

— FibroGen 3.8%

Value $7.937M Shares 130,646 Est. Cost $27.34 Unrealized —

— Cidara Therapeutics 3.1%

Value $6.639M Shares 1,508,794 Est. Cost $6.73 Unrealized —

— CymaBay Therapeutics 2.9%

Value $6.11M Shares 551,477 Est. Cost $4.71 Unrealized —

— Pieris Pharmaceuticals 2.1%

Value $4.358M Shares 778,230 Est. Cost $1.83 Unrealized —

— Jounce Therapeutics 1.6%

Value $3.445M Shares 529,965 Est. Cost $21.99 Unrealized —

— Dicerna Pharmaceuticals 1.6%

Value $3.41M Shares 223,457 Est. Cost $16.47 Unrealized —

— ESSA Pharma 1.5%

Value $3.256M Shares 1,084,848 Est. Cost $3.00 Unrealized —

— Egalet 0.2%

Value $359K Shares 2,889,926 Est. Cost $5.98 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune	5,103,455	$82.17M	38.9%	$17.53	0.0%	Common Stock	76029N106
—	Paratek Pharmaceuticals	2,600,410	$25.22M	11.9%	$34.18	—	Common Stock	699374302
—	Translate Bio	2,437,601	$24.38M	11.5%	$12.65	—	Common Stock	89374L104
—	ObsEva	999,364	$18.02M	8.5%	$9.76	—	Common Stock	H5861P103
—	Kezar Life Sciences	693,272	$14.84M	7.0%	$17.30	—	Common Stock	49372L100
SNNAQ	Sienna Biopharmaceuticals	758,610	$11.24M	5.3%	$21.95	-27.6%	Common Stock	82622H108
—	FibroGen	130,646	$7.937M	3.8%	$27.34	—	Common Stock	31572Q808
—	Cidara Therapeutics	1,508,794	$6.639M	3.1%	$6.73	—	Common Stock	171757107
—	CymaBay Therapeutics	551,477	$6.11M	2.9%	$4.71	—	Common Stock	23257D103
—	Pieris Pharmaceuticals	778,230	$4.358M	2.1%	$1.83	—	Common Stock	720795103
—	Jounce Therapeutics	529,965	$3.445M	1.6%	$21.99	—	Common Stock	481116101
—	Dicerna Pharmaceuticals	223,457	$3.41M	1.6%	$16.47	—	Common Stock	253031108
—	ESSA Pharma	1,084,848	$3.256M	1.5%	$3.00	—	Common Stock	29668H708
—	Egalet	2,889,926	$359K	0.2%	$5.98	—	Common Stock	28226B104